Matthias Kalbus

789 total citations
14 papers, 667 citations indexed

About

Matthias Kalbus is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Matthias Kalbus has authored 14 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in Matthias Kalbus's work include T-cell and B-cell Immunology (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunotherapy and Immune Responses (8 papers). Matthias Kalbus is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunotherapy and Immune Responses (8 papers). Matthias Kalbus collaborates with scholars based in Germany, United States and Slovakia. Matthias Kalbus's co-authors include Roland Martinꝉ, Anne B. Vogt, Hubert Kalbacher, Henry F. McFarland, Marco Vergelli, Harald Kropshofer, J E Coligan, H-G Rammensee, Laura R. Tranquill and Bernhard Hemmer and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Matthias Kalbus

14 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Kalbus Germany 12 539 200 174 97 74 14 667
Sarah Pogue United States 10 545 1.0× 153 0.8× 127 0.7× 68 0.7× 119 1.6× 13 776
PM Guyre United States 7 343 0.6× 213 1.1× 217 1.2× 56 0.6× 91 1.2× 10 631
Alexey Boiko Russia 6 208 0.4× 185 0.9× 233 1.3× 55 0.6× 35 0.5× 8 432
Lourdes Places Spain 16 455 0.8× 182 0.9× 127 0.7× 46 0.5× 108 1.5× 33 685
Jan Wormmeester Netherlands 7 361 0.7× 81 0.4× 42 0.2× 90 0.9× 54 0.7× 12 503
Jean‐Michel Goust United States 12 164 0.3× 153 0.8× 52 0.3× 51 0.5× 32 0.4× 17 444
Maike Gallwitz Sweden 8 368 0.7× 174 0.9× 64 0.4× 37 0.4× 54 0.7× 11 556
Y Oshimi Japan 13 418 0.8× 192 1.0× 49 0.3× 75 0.8× 103 1.4× 21 606
A Parnassa United States 8 419 0.8× 351 1.8× 339 1.9× 55 0.6× 46 0.6× 9 828
Mahmood Khan United Kingdom 6 309 0.6× 82 0.4× 57 0.3× 35 0.4× 36 0.5× 6 458

Countries citing papers authored by Matthias Kalbus

Since Specialization
Citations

This map shows the geographic impact of Matthias Kalbus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Kalbus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Kalbus more than expected).

Fields of papers citing papers by Matthias Kalbus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Kalbus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Kalbus. The network helps show where Matthias Kalbus may publish in the future.

Co-authorship network of co-authors of Matthias Kalbus

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Kalbus. A scholar is included among the top collaborators of Matthias Kalbus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Kalbus. Matthias Kalbus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Muraro, Paolo A., et al.. (2002). T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients. Journal of Neuroimmunology. 130(1-2). 233–242. 34 indexed citations
2.
Kalbus, Matthias, Burkhard Fleckenstein, Martin Blüggel, et al.. (2001). Ligand motif of the autoimmune disease-associated mouse MHC class II molecule H2-As. European Journal of Immunology. 31(2). 551–562. 18 indexed citations
3.
Jung, Christine, Matthias Kalbus, Burkhard Fleckenstein, et al.. (1998). New ligands for HLA DRB1*0301 by random selection of favourable amino acids ranked by competition studies with undecapeptide amide sublibraries. Journal of Immunological Methods. 219(1-2). 139–149. 10 indexed citations
4.
Vergelli, Marco, Valérie Pinet, Anne B. Vogt, et al.. (1997). HLA‐DR‐restricted presentation of purified myelin basic protein is independent of intracellular processing. European Journal of Immunology. 27(4). 941–951. 44 indexed citations
5.
Vergelli, Marco, Bernhard Hemmer, Matthias Kalbus, et al.. (1997). Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. The Journal of Immunology. 158(8). 3746–3752. 74 indexed citations
6.
Muraro, Paolo A., Matthias Kalbus, R. J. Thompson, et al.. (1997). 2′,3′-cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases. Journal of Neuroimmunology. 75(1-2). 28–34. 25 indexed citations
7.
Vergelli, Marco, Matthias Kalbus, Bernhard Hemmer, et al.. (1997). T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells. Journal of Neuroimmunology. 77(2). 195–203. 48 indexed citations
8.
Muraro, Paolo A., Marco Vergelli, Matthias Kalbus, et al.. (1997). Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.. Journal of Clinical Investigation. 100(2). 339–349. 88 indexed citations
9.
Vergelli, Marco, Bernhard Hemmer, Ursula Utz, et al.. (1996). Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87–99). European Journal of Immunology. 26(11). 2624–2634. 84 indexed citations
10.
Vogt, Anne B., Harald Kropshofer, Hubert Kalbacher, et al.. (1994). Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.. The Journal of Immunology. 153(4). 1665–1673. 151 indexed citations
11.
Halder, Thomas, et al.. (1994). A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide. Human Immunology. 41(1). 39–45. 25 indexed citations
12.
Kalbus, Matthias, et al.. (1994). T-cell-reactivity against CNPase (a minor myelin component) in multiple sclerosis patients and normals. Journal of Neuroimmunology. 54(1-2). 191–191. 1 indexed citations
13.
Kropshofer, Harald, et al.. (1993). Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.. The Journal of Immunology. 151(9). 4732–4742. 35 indexed citations
14.
Halder, Thomas, et al.. (1993). Characterization of peptides bound to extracellular and intracellular HLA-DR1 molecules. Human Immunology. 38(3). 193–200. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026